azathioprine has been researched along with Pancreatitis in 136 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Pancreatitis: INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis.
Excerpt | Relevance | Reference |
---|---|---|
"A case of acute pancreatitis induced by azathioprine presented in a 22-year-old patient with Crohn's disease is reported." | 8.80 | [Acute azathioprine-induced pancreatitis in a female patient with Crohn's disease]. ( Caro-Paton, A; Fernández, P; González, JM; Goyeneche, ML; Martín, MA; Remacha, B; Sánchez, G; Velicia, MR, 1999) |
"The immunosuppressant drug azathioprine is associated with a 4% risk of acute pancreatitis in patients with inflammatory bowel disease (IBD)." | 8.12 | HLA variants associated with azathioprine-induced pancreatitis in patients with Crohn's disease. ( Ås, J; Bertulyte, I; Eriksson, N; Hallberg, P; Magnusson, PKE; Wadelius, M, 2022) |
"Azathioprine (AZA)-induced pancreatitis (AIP) is a common, idiosyncratic adverse effect whose incidence and risk factors data in inflammatory bowel disease (IBD) patients are not fully clarified." | 8.12 | Finding Predictors of Azathioprine-Induced Pancreatitis in Patients With Inflammatory Bowel Disease. ( Arieira, C; Cotter, J; Cúrdia Gonçalves, T; Dias de Castro, F; Firmino-Machado, J; Freitas, M; Lima Capela, T; Macedo Silva, V; Moreira, MJ, 2022) |
"The aim of the study was to identify the frequency of azathioprine-induced acute pancreatitis (AZA-AP) and related factors." | 8.02 | Frequency, Predisposing Factors, and Clinical Outcome of Azathioprine-Induced Pancreatitis Among Patients With Inflammatory Bowel Disease: Results From a Tertiary Referral Center. ( Atay, K; Bozcan, S; Celik, AF; Celik, S; Demir, N; Erzin, Y; Eskazan, T; Hatemi, I; Tuncer, M; Yildirim, S, 2021) |
"Azathioprine-induced pancreatitis is an idiosyncratic and unpredictable response, occurring in up to 7% of azathioprine-exposed patients with inflammatory bowel disease (IBD)." | 8.02 | Pretreatment HLADQA1-HLADRB1 Testing for the Prevention of Azathioprine-Induced Pancreatitis in Inflammatory Bowel Disease: A Prospective Cohort Study. ( Beaton, M; Chande, N; Choi, YH; Gregor, JC; Kim, RB; Ponich, T; Sey, M; Wang, Q; Wilson, A; Yan, B, 2021) |
"Studies have shown an association between use of azathioprine and increased risk of acute pancreatitis in adult inflammatory bowel disease." | 7.91 | Association between use of azathioprine and risk of acute pancreatitis in children with inflammatory bowel disease: a Swedish-Danish nationwide cohort study. ( Ludvigsson, JF; Melbye, M; Olén, O; Pasternak, B; Svanström, H; Wintzell, V, 2019) |
"Azathioprine (AZA)-induced pancreatitis is an unpredictable and dose-independent adverse event affecting 2%-7% of patients with inflammatory bowel disease (IBD) patients treated with AZA." | 7.88 | HLA-DQA1-HLA-DRB1 polymorphism is a major predictor of azathioprine-induced pancreatitis in patients with inflammatory bowel disease. ( Beaton, M; Chande, N; Gregor, JC; Jairath, V; Jansen, LE; Khanna, N; Khanna, R; Kim, RB; McIntosh, K; Ponich, T; Rose, RV; Sey, M; Teft, WA; Wilson, A; Yan, B, 2018) |
"We describe two children with CD in whom MP were successfully trialled after a confirmed azathioprine-induced pancreatitis, being well tolerated in both cases." | 7.81 | Successful Mercaptopurine Usage despite Azathioprine-Induced Pancreatitis in Paediatric Crohn's Disease. ( Bartosova, L; Blasco-Alonso, J; Fernández-Crehuet, FG; Gallego-Gutiérrez, S; García-Galán, P; Kolorz, M; Lukac, K; Luque-Pérez, S; Navas-López, VM; Núñez-Caro, L; Serrano-Nieto, MJ; Sierra-Salinas, C, 2015) |
"In this case, the combination of steroids with tacrolimus seems to be a reasonable alternative in a patient with steroid-dependent and thiopurine-refractory autoimmune pancreatitis with IgG4-associated cholangitis." | 7.80 | Tacrolimus as a reasonable alternative in a patient with steroid-dependent and thiopurine-refractory autoimmune pancreatitis with IgG4-associated cholangitis. ( Buechter, M; Canbay, A; Gerken, G; Kahraman, A; Klein, CG; Kloeters, C; Schlaak, JF, 2014) |
"Azathioprine induced pancreatitis usually runs a benign self limited course with rapid disappearance of signs and symptoms upon with drawl of the drug." | 7.77 | Azathioprine induced pancreatitis in a patient with co-existing autoimmune pancreatitis and hepatitis. ( Navaneethan, U; Venkatesh, PG, 2011) |
"We hypothesized that the presence of pancreatic autoantibodies in Crohn's disease patients is associated with the development of azathioprine-induced pancreatitis." | 7.74 | Are pancreatic autoantibodies associated with azathioprine-induced pancreatitis in Crohn's disease? ( Batstra, MR; Kleibeuker, JH; van Dullemen, HM; Weersma, RK, 2008) |
"Azathioprine has been linked to subsequent acute pancreatitis in several case reports and small case series." | 7.72 | Risk of acute pancreatitis in users of azathioprine: a population-based case-control study. ( Floyd, A; Nielsen, GL; Pedersen, L; Sorensen, HT; Thorlacius-Ussing, O, 2003) |
"We have described a 22-year-old man with an HBsAg-positive chronic active hepatitis who developed an attack of pancreatitis during the course of treatment with prednisone and azathioprine." | 7.67 | Azathioprine-associated acute pancreatitis in the course of chronic active hepatitis. ( Grandjean, E; Guillaume, P; Malè, PJ, 1984) |
"Acute pancreatitis was diagnosed in 2 dogs given azathioprine and prednisone." | 7.67 | Acute pancreatitis in two dogs given azathioprine and prednisone. ( Bowen, D; Meyer, DJ; Moriello, KA, 1987) |
" Acute pancreatitis developed, which we could not relate to her lupus, prednisone administration, viral illness, or other causes." | 7.66 | Acute pancreatitis associated with long-term azathioprine therapy. Occurrence in a patient with systemic lupus erythematosus. ( Herskowitz, LJ; Lang, PG; Olansky, S, 1979) |
"Recent controlled clinical trials have documented the development of acute pancreatitis in 5% of patients receiving azathioprine for Crohn's disease, by far the highest incidence of drug-induced pancreatitis recorded to date." | 7.66 | Azathioprine and acute pancreatitis: studies with an isolated perfused canine pancreas. ( Broe, PJ; Cameron, JL, 1983) |
"A retrospective review of the literature has been carried out to determine laboratory abnormalities occurring in patients with rheumatoid arthritis (RA) treated with azathioprine, in order to establish a profile for this agent in the treatment of this disease." | 7.66 | Rheumatoid arthritis: treatment with azathioprine (IMURAN (R)). Clinical side-effects and laboratory abnormalities. ( Pelkey, J; Whisnant, JK, 1982) |
"Azathioprine therapy in a patient with granulomatous ileocolitis was associated with an attack of acute pancreatitis, which was confirmed by laparotomy." | 7.65 | Azathioprine-associated acute pancreatitis. ( Levin, B; Paloyan, D; Simonowitz, D, 1977) |
"Azathioprine (AZA) is a commonly used immunosuppressive therapy that has been implicated in a number of cutaneous and systemic inflammatory reactions." | 5.91 | Azathioprine hypersensitivity syndrome manifesting as subcutaneous Sweet syndrome and acute pancreatitis. ( Harp, J; Magro, C; Tee, MW; Thomas, JL, 2023) |
"Drug-induced acute pancreatitis (DIAP) is an often-neglected entity where the disorder is the consequence of the toxic effects of various agents applied to treat potentially life-threatening conditions, such as inflammatory bowel disease." | 5.56 | Recurrent acute pancreatitis induced by 5-ASA and azathioprine in ulcerative colitis. ( Bajor, J; Faluhelyi, N; Hegyi, P; Hegyi, PJ; Németh, BC; Szakács, Z, 2020) |
" Oral prednisolone treatment was initiated at 30 mg/day, and the dosage was gradually decreased." | 5.43 | A case of autoimmune pancreatitis effectively treated with an immunosuppressant (azathioprine). ( Arakawa, N; Fujisawa, M; Igarashi, R; Ikeda, T; Irisawa, A; Maki, T; Notohara, K; Sato, A; Shibukawa, G; Yamabe, A; Yamamoto, S; Yoshida, Y, 2016) |
"AZA-induced acute pancreatitis is a common adverse event in IBD patients, but in this study had a mild course in all patients." | 5.43 | Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases--A Prospective Study on Incidence and Severity. ( Bokemeyer, B; Bündgens, B; Büning, J; Drabik, A; Helwig, U; Hüppe, D; Klugmann, T; Kruis, W; Maaser, C; Miehlke, S; Mohl, W; Siegmund, B; Stallmach, A; Teich, N; Weismüller, J, 2016) |
"In addition, acute pancreatitis is one of the extra-intestinal manifestations of acute exacerbation of CD without the previous use of azathioprine." | 5.35 | [Acute pancreatitis following azathioprine therapy of crohn's disease--a case report and the overview of the literature]. ( Koren, M; Potrc, S; Sinkovic, A; Skok, P, 2008) |
"Sclerosing sialadenitis occurred before AIP, whereas autoimmune sensorineural hearing loss, allergic purpura and endocapillary proliferative glomerulonephritis occurred after AIP." | 5.35 | Autoimmune pancreatitis associated with various extrapancreatic lesions during a long-term clinical course successfully treated with azathioprine and corticosteroid maintenance therapy. ( Ando, T; Hayashi, K; Joh, T; Miyabe, K; Naitoh, I; Nakazawa, T; Ohara, H; Okumura, F; Sano, H; Takahashi, S; Tanaka, H; Yoshida, M, 2009) |
"Pancreatitis is a potentially severe condition." | 5.35 | Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis. ( Algaba, A; Bermejo, F; Calvo, M; Carneros, JA; Gisbert, JP; López, P; Lopez-Sanroman, A; Luna, M; Martín-Arranz, MD; Menchén, L; Mendoza, JL; Opio, V; Pérez-Calle, JL; Taxonera, C; Van-Domselaar, M; Vera, I, 2008) |
"Acute pancreatitis is rarely seen when azathioprine is used for other diseases than Crohn's disease." | 5.32 | Increased incidence of azathioprine-induced pancreatitis in Crohn's disease compared with other diseases. ( Homan van der Heide, JJ; Jansen, PL; Oostenbrug, LE; Peters, FT; Ploeg, RJ; Posthumus, MD; van den Berg, AP; van Dullemen, HM; van Haastert, M; Weersma, RK, 2004) |
" The thiopurine drugs, azathioprine and 6-mercaptopurine, are commonly used to maintain remission in Crohn's disease and ulcerative colitis; however, the use of these drugs may be limited by the development of pancreatitis in some individuals." | 4.91 | Thiopurine-induced pancreatitis in inflammatory bowel diseases. ( Day, AS; Ledder, O; Lemberg, DA, 2015) |
"A case of acute pancreatitis induced by azathioprine presented in a 22-year-old patient with Crohn's disease is reported." | 4.80 | [Acute azathioprine-induced pancreatitis in a female patient with Crohn's disease]. ( Caro-Paton, A; Fernández, P; González, JM; Goyeneche, ML; Martín, MA; Remacha, B; Sánchez, G; Velicia, MR, 1999) |
" Less convincing, but suggestive evidence exists for: 1-asparaginase, iatrogenic hypercalcemia, chlorthalidine, corticosteroids, ethacrynic acid, phenformin, and procainamide." | 4.76 | Drug-induced pancreatitis: a critical review. ( Kern, F; Mallory, A, 1980) |
" Fifty-one instances were caused by steroids or adrenocorticotropic hormone, six by estrogen, two by azathioprine, 16 by diurectics, two by hypercalcemia, 24 by chemotherapy, three by clonidine and phenformin, two by warfarin and one each by salicylate, 1-asparaginase and d-propoxyphene." | 4.75 | Drug-induced acute pancreatitis. ( Howard, JM; Nakashima, Y, 1977) |
"Azathioprine (AZA)-induced pancreatitis (AIP) is a common, idiosyncratic adverse effect whose incidence and risk factors data in inflammatory bowel disease (IBD) patients are not fully clarified." | 4.12 | Finding Predictors of Azathioprine-Induced Pancreatitis in Patients With Inflammatory Bowel Disease. ( Arieira, C; Cotter, J; Cúrdia Gonçalves, T; Dias de Castro, F; Firmino-Machado, J; Freitas, M; Lima Capela, T; Macedo Silva, V; Moreira, MJ, 2022) |
"The immunosuppressant drug azathioprine is associated with a 4% risk of acute pancreatitis in patients with inflammatory bowel disease (IBD)." | 4.12 | HLA variants associated with azathioprine-induced pancreatitis in patients with Crohn's disease. ( Ås, J; Bertulyte, I; Eriksson, N; Hallberg, P; Magnusson, PKE; Wadelius, M, 2022) |
"Azathioprine-induced pancreatitis is an idiosyncratic and unpredictable response, occurring in up to 7% of azathioprine-exposed patients with inflammatory bowel disease (IBD)." | 4.02 | Pretreatment HLADQA1-HLADRB1 Testing for the Prevention of Azathioprine-Induced Pancreatitis in Inflammatory Bowel Disease: A Prospective Cohort Study. ( Beaton, M; Chande, N; Choi, YH; Gregor, JC; Kim, RB; Ponich, T; Sey, M; Wang, Q; Wilson, A; Yan, B, 2021) |
"The aim of the study was to identify the frequency of azathioprine-induced acute pancreatitis (AZA-AP) and related factors." | 4.02 | Frequency, Predisposing Factors, and Clinical Outcome of Azathioprine-Induced Pancreatitis Among Patients With Inflammatory Bowel Disease: Results From a Tertiary Referral Center. ( Atay, K; Bozcan, S; Celik, AF; Celik, S; Demir, N; Erzin, Y; Eskazan, T; Hatemi, I; Tuncer, M; Yildirim, S, 2021) |
"Studies have shown an association between use of azathioprine and increased risk of acute pancreatitis in adult inflammatory bowel disease." | 3.91 | Association between use of azathioprine and risk of acute pancreatitis in children with inflammatory bowel disease: a Swedish-Danish nationwide cohort study. ( Ludvigsson, JF; Melbye, M; Olén, O; Pasternak, B; Svanström, H; Wintzell, V, 2019) |
"Azathioprine (AZA)-induced pancreatitis is an unpredictable and dose-independent adverse event affecting 2%-7% of patients with inflammatory bowel disease (IBD) patients treated with AZA." | 3.88 | HLA-DQA1-HLA-DRB1 polymorphism is a major predictor of azathioprine-induced pancreatitis in patients with inflammatory bowel disease. ( Beaton, M; Chande, N; Gregor, JC; Jairath, V; Jansen, LE; Khanna, N; Khanna, R; Kim, RB; McIntosh, K; Ponich, T; Rose, RV; Sey, M; Teft, WA; Wilson, A; Yan, B, 2018) |
"We describe two children with CD in whom MP were successfully trialled after a confirmed azathioprine-induced pancreatitis, being well tolerated in both cases." | 3.81 | Successful Mercaptopurine Usage despite Azathioprine-Induced Pancreatitis in Paediatric Crohn's Disease. ( Bartosova, L; Blasco-Alonso, J; Fernández-Crehuet, FG; Gallego-Gutiérrez, S; García-Galán, P; Kolorz, M; Lukac, K; Luque-Pérez, S; Navas-López, VM; Núñez-Caro, L; Serrano-Nieto, MJ; Sierra-Salinas, C, 2015) |
"In this case, the combination of steroids with tacrolimus seems to be a reasonable alternative in a patient with steroid-dependent and thiopurine-refractory autoimmune pancreatitis with IgG4-associated cholangitis." | 3.80 | Tacrolimus as a reasonable alternative in a patient with steroid-dependent and thiopurine-refractory autoimmune pancreatitis with IgG4-associated cholangitis. ( Buechter, M; Canbay, A; Gerken, G; Kahraman, A; Klein, CG; Kloeters, C; Schlaak, JF, 2014) |
"Mesalamine and thiopurines (6-mercaptopurine and azathioprine) have been shown to increase the risk of developing acute pancreatitis in inflammatory bowel disease (IBD) patients." | 3.80 | Effect of tumor necrosis factor-α inhibitors on drug-induced pancreatitis in inflammatory bowel disease. ( Deepak, P; Stobaugh, DJ, 2014) |
"Pancreatitis occurs in approximately 4% of patients treated with the thiopurines azathioprine or mercaptopurine." | 3.80 | HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants. ( Ahmad, T; Andrews, JM; Annese, V; Bampton, P; Barnardo, M; Bell, S; Bewshea, CM; Chen, M; Cole, A; Connor, SJ; Creed, T; Cummings, FR; D'Amato, M; Daneshmend, TK; Dubois, PC; Fedorak, RN; Florin, TH; Gaya, DR; Greig, E; Halfvarson, J; Hart, A; Heap, GA; Holden, AL; Irving, PM; Jones, G; Karban, A; Lawrance, IC; Lee, JC; Lees, C; Lev-Tzion, R; Lindsay, JO; Mansfield, J; Mawdsley, J; Mazhar, Z; Orchard, TR; Parkes, M; Parnell, K; Radford-Smith, G; Reffitt, D; Rossjohn, J; Russell, RK; Satchwell, JB; Satsangi, J; Silverberg, MS; Singh, A; So, K; Sturniolo, GC; Tremelling, M; Tsianos, EV; van Heel, DA; Vivian, JP; Walsh, A; Watermeyer, G; Weedon, MN; Weersma, RK; Zeissig, S, 2014) |
" Four cases are presented of TIP appropriately related temporally to azathioprine commencement, with no other apparent cause of pancreatitis identified." | 3.79 | Are thiopurines always contraindicated after thiopurine-induced pancreatitis in inflammatory bowel disease? ( Day, AS; Ledder, OD; Lemberg, DA; Ooi, CY, 2013) |
"Azathioprine induced pancreatitis usually runs a benign self limited course with rapid disappearance of signs and symptoms upon with drawl of the drug." | 3.77 | Azathioprine induced pancreatitis in a patient with co-existing autoimmune pancreatitis and hepatitis. ( Navaneethan, U; Venkatesh, PG, 2011) |
"We hypothesized that the presence of pancreatic autoantibodies in Crohn's disease patients is associated with the development of azathioprine-induced pancreatitis." | 3.74 | Are pancreatic autoantibodies associated with azathioprine-induced pancreatitis in Crohn's disease? ( Batstra, MR; Kleibeuker, JH; van Dullemen, HM; Weersma, RK, 2008) |
" Azathioprine has a significant early adverse reaction (EAR) profile, which includes an acute syndrome of constitutional symptoms, fever, rash, and acute pancreatitis and often requires discontinuation of drug." | 3.73 | Increased rates of early adverse reaction to azathioprine in patients with Crohn's disease compared to autoimmune hepatitis: a tertiary referral center experience. ( Bajaj, JS; Binion, DG; Emmons, J; Franco, J; Knox, JF; Levy, M; Podoll, J; Saeian, K; Varma, RR, 2005) |
"Of all azathioprine treated patients, 11 experienced an adverse event for which azathioprine was stopped: pancreatitis (n = 4), leucopenia (n = 2) and 'general malaise' (n = 5)." | 3.73 | Pharmacogenetics of thiopurine therapy in paediatric IBD patients. ( Benninga, MA; De Ridder, L; Escher, JC; Hommes, DW; Stokkers, PC; Van der Woude, JC; Van Deventer, HJ; Van Dieren, JM; Van Vuuren, AJ, 2006) |
"Azathioprine has been linked to subsequent acute pancreatitis in several case reports and small case series." | 3.72 | Risk of acute pancreatitis in users of azathioprine: a population-based case-control study. ( Floyd, A; Nielsen, GL; Pedersen, L; Sorensen, HT; Thorlacius-Ussing, O, 2003) |
" The intracystic hemorrhage in our case may have been related to a rapid tumor growth due to weakened antitumor immunity and azathioprine-induced pancreatitis." | 3.70 | Intracystic hemorrhage of pancreatic serous cystadenoma after renal transplantation: report of a case. ( Baba, S; Fujita, K; Harada, M; Ishikawa, A; Konno, H; Nakamura, S; Sakaguchi, T; Suzuki, K; Suzuki, S; Ushiyama, T, 2000) |
"We have described a 22-year-old man with an HBsAg-positive chronic active hepatitis who developed an attack of pancreatitis during the course of treatment with prednisone and azathioprine." | 3.67 | Azathioprine-associated acute pancreatitis in the course of chronic active hepatitis. ( Grandjean, E; Guillaume, P; Malè, PJ, 1984) |
"Acute pancreatitis was diagnosed in 2 dogs given azathioprine and prednisone." | 3.67 | Acute pancreatitis in two dogs given azathioprine and prednisone. ( Bowen, D; Meyer, DJ; Moriello, KA, 1987) |
" Acute pancreatitis developed, which we could not relate to her lupus, prednisone administration, viral illness, or other causes." | 3.66 | Acute pancreatitis associated with long-term azathioprine therapy. Occurrence in a patient with systemic lupus erythematosus. ( Herskowitz, LJ; Lang, PG; Olansky, S, 1979) |
"A retrospective review of the literature has been carried out to determine laboratory abnormalities occurring in patients with rheumatoid arthritis (RA) treated with azathioprine, in order to establish a profile for this agent in the treatment of this disease." | 3.66 | Rheumatoid arthritis: treatment with azathioprine (IMURAN (R)). Clinical side-effects and laboratory abnormalities. ( Pelkey, J; Whisnant, JK, 1982) |
"Recent controlled clinical trials have documented the development of acute pancreatitis in 5% of patients receiving azathioprine for Crohn's disease, by far the highest incidence of drug-induced pancreatitis recorded to date." | 3.66 | Azathioprine and acute pancreatitis: studies with an isolated perfused canine pancreas. ( Broe, PJ; Cameron, JL, 1983) |
"Azathioprine therapy in a patient with granulomatous ileocolitis was associated with an attack of acute pancreatitis, which was confirmed by laparotomy." | 3.65 | Azathioprine-associated acute pancreatitis. ( Levin, B; Paloyan, D; Simonowitz, D, 1977) |
"Our cases demonstrate resemblances with autoimmune pancreatitis based on clinical and imaging findings." | 3.01 | Immune Checkpoint Inhibitor-related Pancreatitis: A Case Series, Review of the Literature and an Expert Opinion. ( Blokzijl, H; Kramer, S; van der Heide, F; van Hee, K; Visschedijk, MC, 2023) |
"The risk of acute pancreatitis in patients with IBD is increased due to the higher incidence of cholelithiasis and drug-induced pancreatitis in this population." | 2.82 | Pancreatic Disorders in Patients with Inflammatory Bowel Disease. ( Bi, Y; Corral, JE; Farraye, FA; Ji, B; Kröner, PT; Lukens, FJ; Montenegro, ML, 2022) |
"Acute pancreatitis is an uncommon complication that occurs in 0." | 2.61 | Corticosteroid-associated lupus pancreatitis: a case series and systematic review of the literature. ( Adarsh, MB; Dhir, V; Dhooria, A; Dwivedi, P; Jain, S; Kakkar, N; Kumar, RR; Malhotra, S; Naidu, S; Sharma, A; Sharma, SK, 2019) |
" Fortunately, the absolute incidence of serious toxicity remains low, and an improved understanding of how best to minimize risk and the recognition of groups of patients at higher risk of toxicity from thiopurines means that they remain a relatively safe therapy in the majority of patients." | 2.52 | Toxicity and response to thiopurines in patients with inflammatory bowel disease. ( Goldberg, R; Irving, PM, 2015) |
" Patients' derived iPSC are an innovative model to study mechanisms of adverse drug reactions in individual patients and in cell types that cannot be easily obtained from human subjects." | 2.52 | Patients' Induced Pluripotent Stem Cells to Model Drug Induced Adverse Events: A Role in Predicting Thiopurine Induced Pancreatitis? ( Decorti, G; Giliani, S; Lanzi, G; Martelossi, S; Pelin, M; Sasaki, K; Stocco, G; Tommasini, A; Ventura, A; Yue, F, 2015) |
"Crohn's disease and ulcerative colitis, together popularly known as inflammatory bowel disease (IBD), are characterized by a number of extraintestinal manifestations." | 2.46 | Pancreatitis in inflammatory bowel diseases. ( Das, K; Pitchumoni, CS; Rubin, A, 2010) |
" Adverse effects occur in about 15% of patients." | 2.40 | Azathioprine in inflammatory bowel disease, a safe alternative? ( Tanis, AA, 1998) |
"Azathioprine (AZA) is a commonly used immunosuppressive therapy that has been implicated in a number of cutaneous and systemic inflammatory reactions." | 1.91 | Azathioprine hypersensitivity syndrome manifesting as subcutaneous Sweet syndrome and acute pancreatitis. ( Harp, J; Magro, C; Tee, MW; Thomas, JL, 2023) |
"Thioguanine (TG) has been shown as a safe alternative in adults with inflammatory bowel disease (IBD) who did not tolerate conventional thiopurines [azathioprine (AZA)/mercaptopurine]." | 1.72 | Safety of Thioguanine in Pediatric Inflammatory Bowel Disease: A Multi-Center Case Series. ( Bayoumy, AB; Benninga, MA; de Boer, NKH; de Meij, TGJ; de Ridder, L; Hummel, T; Jagt, JZ; Mulder, CJJ; Stapelbroek, J; van Wering, HM; Wolters, VM, 2022) |
" In this report, we describe the safe and effective use of trametinib combined with dasatinib in a patient with acute lymphoblastic leukemia (ALL)." | 1.62 | Successful use of trametinib and dasatinib combined with chemotherapy in the treatment of Ph-positive B-cell acute lymphoblastic leukemia: A case report. ( Hu, BF; Shen, SH; Wang, GL; Wang, J, 2021) |
"Drug-induced acute pancreatitis (DIAP) is an often-neglected entity where the disorder is the consequence of the toxic effects of various agents applied to treat potentially life-threatening conditions, such as inflammatory bowel disease." | 1.56 | Recurrent acute pancreatitis induced by 5-ASA and azathioprine in ulcerative colitis. ( Bajor, J; Faluhelyi, N; Hegyi, P; Hegyi, PJ; Németh, BC; Szakács, Z, 2020) |
"After exclusion of pancreatic cancer and other common causes of acute pancreatitis, the diagnosis of AIP was suspected." | 1.48 | Autoimmune Pancreatitis and Ulcerative Rectocolitis in an Adolescent. ( Aziz, K; Breton, E; Chailloux, P; Cousin, E; Cousin, I, 2018) |
"However, disease relapse is common in long-term follow-up, despite a successful initial treatment response." | 1.48 | Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment. ( Cho, DH; Jun, JH; Kim, MH; Lee, HW; Lee, SK; Lee, SS; Moon, SH; Nam, K; Park, DH; Seo, DW; Song, TJ, 2018) |
"AZA-induced acute pancreatitis is a common adverse event in IBD patients, but in this study had a mild course in all patients." | 1.43 | Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases--A Prospective Study on Incidence and Severity. ( Bokemeyer, B; Bündgens, B; Büning, J; Drabik, A; Helwig, U; Hüppe, D; Klugmann, T; Kruis, W; Maaser, C; Miehlke, S; Mohl, W; Siegmund, B; Stallmach, A; Teich, N; Weismüller, J, 2016) |
" Oral prednisolone treatment was initiated at 30 mg/day, and the dosage was gradually decreased." | 1.43 | A case of autoimmune pancreatitis effectively treated with an immunosuppressant (azathioprine). ( Arakawa, N; Fujisawa, M; Igarashi, R; Ikeda, T; Irisawa, A; Maki, T; Notohara, K; Sato, A; Shibukawa, G; Yamabe, A; Yamamoto, S; Yoshida, Y, 2016) |
" The major drawback of these drugs are their serious adverse effects (SAE), highlighting the importance of preemptive identification of patients at risk." | 1.39 | Risk factors for serious adverse effects of thiopurines in patients with Crohn's disease. ( Chowers, Y; Efrati, E; Elkin, H; Karban, A; Koifman, E; Krivoy, N; Mazor, Y, 2013) |
"While causes of pancreatitis have been extensively analyzed, different series reported different causes." | 1.38 | Acute and recurrent pancreatitis in children: exploring etiological factors. ( De Cunto, A; Martelossi, S; Minen, F; Ventura, A, 2012) |
"We report 2 cases of thiopurine-induced acute pancreatitis in patients with inflammatory bowel disease." | 1.38 | [Two cases of thiopurine-induced acute pancreatitis in inflammatory bowel disease]. ( Ando, T; Fujinami, H; Hosokawa, A; Kajiura, S; Kudo, T; Mihara, H; Miyazaki, T; Nishikawa, J; Ogawa, K; Sugiyama, T; Ueda, A, 2012) |
"The probability of AIP recurrence was assessed by using Kaplan-Meier curves and the unadjusted Cox model." | 1.37 | Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence. ( Bonatti, M; Frulloni, L; Graziani, R; Manfredi, R; Mantovani, W; Pozzi Mucelli, R, 2011) |
"Azathioprine was the most frequent causative factor (three cases in two patients); all the other causative drugs were documented only in single cases: mesalazine, dexamethasone, ramipril, mycophenolate mofetil, cytarabine, and valproate." | 1.36 | Incidence, severity, and etiology of drug-induced acute pancreatitis. ( Procházka, M; Procházka, V; Urbánek, K; Vinklerová, I, 2010) |
"Pancreatitis is a potentially severe condition." | 1.35 | Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis. ( Algaba, A; Bermejo, F; Calvo, M; Carneros, JA; Gisbert, JP; López, P; Lopez-Sanroman, A; Luna, M; Martín-Arranz, MD; Menchén, L; Mendoza, JL; Opio, V; Pérez-Calle, JL; Taxonera, C; Van-Domselaar, M; Vera, I, 2008) |
"Sclerosing sialadenitis occurred before AIP, whereas autoimmune sensorineural hearing loss, allergic purpura and endocapillary proliferative glomerulonephritis occurred after AIP." | 1.35 | Autoimmune pancreatitis associated with various extrapancreatic lesions during a long-term clinical course successfully treated with azathioprine and corticosteroid maintenance therapy. ( Ando, T; Hayashi, K; Joh, T; Miyabe, K; Naitoh, I; Nakazawa, T; Ohara, H; Okumura, F; Sano, H; Takahashi, S; Tanaka, H; Yoshida, M, 2009) |
"Acute pancreatitis is a serious disease with fatality rate up to 15%." | 1.35 | [A case of acute pancreatitis induced by multiple drugs in a patient with ulcerative colitis]. ( Choi, HS; Hahm, JS; Han, DS; Joo, YW; Lee, HL; Lee, OY; Son, CN; Yoon, BC, 2008) |
"In addition, acute pancreatitis is one of the extra-intestinal manifestations of acute exacerbation of CD without the previous use of azathioprine." | 1.35 | [Acute pancreatitis following azathioprine therapy of crohn's disease--a case report and the overview of the literature]. ( Koren, M; Potrc, S; Sinkovic, A; Skok, P, 2008) |
"Two patients developed acute pancreatitis." | 1.34 | Thiopurine metabolite monitoring in paediatric inflammatory bowel disease. ( Bohane, TD; Day, AS; Lee, D; Naidoo, D; Ooi, CY, 2007) |
"61); among the 34 responders, the median dosage of the drug required to obtain remission was lower for mutated than for wild type patients (1." | 1.33 | TPMT genotype and the use of thiopurines in paediatric inflammatory bowel disease. ( Barabino, A; Bartoli, F; Decorti, G; Fezzi, M; Fontana, M; Giraldi, T; Lionetti, P; Malusà, N; Martelossi, S; Stocco, G; Ventura, A, 2005) |
"Acute pancreatitis is rarely seen when azathioprine is used for other diseases than Crohn's disease." | 1.32 | Increased incidence of azathioprine-induced pancreatitis in Crohn's disease compared with other diseases. ( Homan van der Heide, JJ; Jansen, PL; Oostenbrug, LE; Peters, FT; Ploeg, RJ; Posthumus, MD; van den Berg, AP; van Dullemen, HM; van Haastert, M; Weersma, RK, 2004) |
"Pancreatitis is the most severe complication of ERCP." | 1.32 | Are drugs a risk factor of post-ERCP pancreatitis? ( Bauret, P; Berthier, E; Blanc, F; Blayac, JP; Fabbro-Peray, P; Hanslik, B; Hillaire-Buys, D; Larrey, D; Melki, M; Pageaux, GP; Perney, P; Roques, V, 2003) |
"The mortality of acute pancreatitis in a kidney transplant patient is, in spite of treatment with the most up-to-date methods, is much higher (53-60%) than that for a non-transplant patient." | 1.31 | [Acute pancreatitis after kidney transplantation]. ( Asztalos, L; Balzs, G; Berczi, C; Fedor, R; Kincses, Z; Locsey, L; Szabo, L, 2001) |
"Pancreatitis was significantly more frequent in girls as compared to boys (P = 0." | 1.31 | [Pancreatic involvement in inflammatory bowel diseases in children]. ( Cézard, JP; Faure, C; Hugot, JP; Le Large-Guiheneuf, C; Mougenot, JF; Munck, A; Navarro, J, 2002) |
"Acute pancreatitis was induced in rats by using a combination of low-dose controlled intraductal glycodeoxycholic acid superimposed on intravenous cerulein hyperstimulation." | 1.30 | Effect of different immunosuppressive agents on acute pancreatitis: a comparative study in an improved animal model. ( Buhr, HJ; Foitzik, T; Forgacs, B; Gebhardt, MM; Hotz, H; Klar, E; Ryschich, E, 1998) |
"Among 1613 patients treated for acute pancreatitis in 1993, drug induced acute pancreatitis was diagnosed in 22 patients (incidence 1." | 1.29 | Drug induced acute pancreatitis: incidence and severity. ( Dröge, M; Gottesleben, F; Lankisch, PG, 1995) |
"The pancreatitis was first manifested by panniculitis of the lower extremities." | 1.27 | Childhood systemic lupus erythematosus. Association with pancreatitis, subcutaneous fat necrosis, and calcinosis cutis. ( Gorman, H; Penneys, N; Schachner, L; Simons-Ling, N; Strauss, J; Zillereulo, G, 1983) |
"Pancreatitis is not a rare occurrence in SLE, and may be related in part to the vasculitis seen during periods of disease activity." | 1.26 | Acute pancreatitis in systemic lupus erythematosus: report of twenty cases and a review of the literature. ( Chuong, JH; Inman, RD; Kimberly, RP; Kovacs, JE; Reynolds, JC; Walsh, MB, 1982) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 40 (29.41) | 18.7374 |
1990's | 14 (10.29) | 18.2507 |
2000's | 30 (22.06) | 29.6817 |
2010's | 40 (29.41) | 24.3611 |
2020's | 12 (8.82) | 2.80 |
Authors | Studies |
---|---|
Eskazan, T | 1 |
Bozcan, S | 1 |
Atay, K | 1 |
Yildirim, S | 1 |
Demir, N | 1 |
Celik, S | 1 |
Tuncer, M | 1 |
Hatemi, I | 1 |
Celik, AF | 1 |
Erzin, Y | 1 |
Ås, J | 1 |
Bertulyte, I | 1 |
Eriksson, N | 1 |
Magnusson, PKE | 1 |
Wadelius, M | 1 |
Hallberg, P | 1 |
Freitas, M | 1 |
Lima Capela, T | 1 |
Macedo Silva, V | 1 |
Arieira, C | 1 |
Cúrdia Gonçalves, T | 1 |
Dias de Castro, F | 1 |
Moreira, MJ | 1 |
Firmino-Machado, J | 1 |
Cotter, J | 1 |
Thomas, JL | 1 |
Tee, MW | 1 |
Harp, J | 1 |
Magro, C | 1 |
Bayoumy, AB | 1 |
Jagt, JZ | 1 |
van Wering, HM | 1 |
de Ridder, L | 2 |
Hummel, T | 1 |
Wolters, VM | 1 |
Stapelbroek, J | 1 |
Benninga, MA | 2 |
Mulder, CJJ | 1 |
de Boer, NKH | 1 |
de Meij, TGJ | 1 |
Kramer, S | 1 |
van Hee, K | 1 |
Blokzijl, H | 1 |
van der Heide, F | 1 |
Visschedijk, MC | 1 |
Chadalavada, P | 1 |
Simons-Linares, CR | 1 |
Chahal, P | 1 |
Gagnon, AL | 1 |
Lavoie, A | 1 |
Frigon, MP | 1 |
Michaud-Herbst, A | 1 |
Tremblay, K | 1 |
Hegyi, PJ | 1 |
Szakács, Z | 1 |
Faluhelyi, N | 1 |
Németh, BC | 1 |
Bajor, J | 1 |
Hegyi, P | 1 |
Montenegro, ML | 1 |
Corral, JE | 1 |
Lukens, FJ | 1 |
Ji, B | 1 |
Kröner, PT | 1 |
Farraye, FA | 1 |
Bi, Y | 1 |
Wilson, A | 3 |
Wang, Q | 1 |
Choi, YH | 1 |
Ponich, T | 3 |
Gregor, JC | 3 |
Chande, N | 3 |
Yan, B | 3 |
Sey, M | 3 |
Beaton, M | 3 |
Kim, RB | 3 |
Wang, J | 1 |
Shen, SH | 1 |
Hu, BF | 1 |
Wang, GL | 1 |
Kotha, S | 1 |
Tritto, G | 1 |
Wong, T | 1 |
Berry, P | 1 |
Jansen, LE | 2 |
Rose, RV | 2 |
Khanna, R | 2 |
Jairath, V | 2 |
Khanna, N | 2 |
McIntosh, K | 2 |
Teft, WA | 2 |
Lee, HW | 1 |
Moon, SH | 1 |
Kim, MH | 1 |
Cho, DH | 1 |
Jun, JH | 1 |
Nam, K | 1 |
Song, TJ | 1 |
Park, DH | 1 |
Lee, SS | 1 |
Seo, DW | 1 |
Lee, SK | 1 |
Teich, N | 3 |
Bruns, T | 2 |
Stallmach, A | 3 |
Brunet, E | 1 |
Martínez de Sola, M | 1 |
Garcia-Iglesias, P | 1 |
Calvet, X | 1 |
Cousin, E | 1 |
Cousin, I | 1 |
Aziz, K | 1 |
Chailloux, P | 1 |
Breton, E | 1 |
Begun, J | 1 |
Sparrow, M | 1 |
Aloi, M | 1 |
Cucchiara, S | 1 |
Wintzell, V | 1 |
Svanström, H | 1 |
Olén, O | 1 |
Melbye, M | 1 |
Ludvigsson, JF | 1 |
Pasternak, B | 1 |
Dwivedi, P | 1 |
Kumar, RR | 1 |
Dhooria, A | 1 |
Adarsh, MB | 1 |
Malhotra, S | 1 |
Kakkar, N | 1 |
Naidu, S | 1 |
Sharma, SK | 1 |
Sharma, A | 2 |
Jain, S | 1 |
Dhir, V | 1 |
Ledder, OD | 1 |
Lemberg, DA | 2 |
Ooi, CY | 2 |
Day, AS | 3 |
Buechter, M | 1 |
Klein, CG | 1 |
Kloeters, C | 1 |
Schlaak, JF | 1 |
Canbay, A | 1 |
Gerken, G | 1 |
Kahraman, A | 1 |
Stobaugh, DJ | 1 |
Deepak, P | 1 |
Rasch, S | 1 |
Phillip, V | 1 |
Weirich, G | 1 |
Esposito, I | 1 |
Gaa, J | 1 |
Schmid, RM | 1 |
Algül, H | 1 |
Heap, GA | 1 |
Weedon, MN | 1 |
Bewshea, CM | 1 |
Singh, A | 1 |
Chen, M | 1 |
Satchwell, JB | 1 |
Vivian, JP | 1 |
So, K | 1 |
Dubois, PC | 1 |
Andrews, JM | 1 |
Annese, V | 1 |
Bampton, P | 1 |
Barnardo, M | 1 |
Bell, S | 1 |
Cole, A | 1 |
Connor, SJ | 1 |
Creed, T | 1 |
Cummings, FR | 1 |
D'Amato, M | 1 |
Daneshmend, TK | 1 |
Fedorak, RN | 1 |
Florin, TH | 1 |
Gaya, DR | 1 |
Greig, E | 1 |
Halfvarson, J | 1 |
Hart, A | 1 |
Irving, PM | 2 |
Jones, G | 1 |
Karban, A | 2 |
Lawrance, IC | 1 |
Lee, JC | 1 |
Lees, C | 1 |
Lev-Tzion, R | 1 |
Lindsay, JO | 1 |
Mansfield, J | 1 |
Mawdsley, J | 1 |
Mazhar, Z | 1 |
Parkes, M | 1 |
Parnell, K | 1 |
Orchard, TR | 1 |
Radford-Smith, G | 1 |
Russell, RK | 1 |
Reffitt, D | 1 |
Satsangi, J | 1 |
Silverberg, MS | 1 |
Sturniolo, GC | 1 |
Tremelling, M | 1 |
Tsianos, EV | 1 |
van Heel, DA | 1 |
Walsh, A | 1 |
Watermeyer, G | 1 |
Weersma, RK | 4 |
Zeissig, S | 1 |
Rossjohn, J | 1 |
Holden, AL | 1 |
Ahmad, T | 1 |
Ledder, O | 1 |
Goldberg, R | 1 |
Gallego-Gutiérrez, S | 1 |
Navas-López, VM | 1 |
Kolorz, M | 2 |
Bartosova, L | 2 |
Lukac, K | 1 |
Luque-Pérez, S | 1 |
Núñez-Caro, L | 1 |
García-Galán, P | 1 |
Fernández-Crehuet, FG | 1 |
Blasco-Alonso, J | 1 |
Serrano-Nieto, MJ | 1 |
Sierra-Salinas, C | 1 |
Mohl, W | 2 |
Bokemeyer, B | 2 |
Bündgens, B | 1 |
Büning, J | 1 |
Miehlke, S | 1 |
Hüppe, D | 1 |
Maaser, C | 1 |
Klugmann, T | 1 |
Kruis, W | 1 |
Siegmund, B | 1 |
Helwig, U | 1 |
Weismüller, J | 1 |
Drabik, A | 1 |
Stocco, G | 2 |
Lanzi, G | 1 |
Yue, F | 1 |
Giliani, S | 1 |
Sasaki, K | 1 |
Tommasini, A | 1 |
Pelin, M | 1 |
Martelossi, S | 3 |
Ventura, A | 3 |
Decorti, G | 2 |
Madhani, K | 1 |
Farrell, JJ | 1 |
Hernanz, N | 1 |
Lopez-Sanroman, A | 2 |
Yamabe, A | 1 |
Irisawa, A | 1 |
Notohara, K | 1 |
Shibukawa, G | 1 |
Fujisawa, M | 1 |
Sato, A | 1 |
Yoshida, Y | 1 |
Arakawa, N | 1 |
Ikeda, T | 1 |
Igarashi, R | 1 |
Maki, T | 1 |
Yamamoto, S | 1 |
Walldorf, J | 1 |
Schmidt, C | 1 |
Bermejo, F | 1 |
Taxonera, C | 1 |
Gisbert, JP | 1 |
Pérez-Calle, JL | 1 |
Vera, I | 1 |
Menchén, L | 1 |
Martín-Arranz, MD | 1 |
Opio, V | 1 |
Carneros, JA | 1 |
Van-Domselaar, M | 1 |
Mendoza, JL | 1 |
Luna, M | 1 |
López, P | 1 |
Calvo, M | 1 |
Algaba, A | 1 |
Matsushita, M | 1 |
Ikeura, T | 1 |
Fukui, T | 1 |
Uchida, K | 1 |
Okazaki, K | 1 |
Son, CN | 1 |
Lee, HL | 1 |
Joo, YW | 1 |
Lee, OY | 1 |
Han, DS | 1 |
Yoon, BC | 1 |
Choi, HS | 1 |
Hahm, JS | 1 |
Sandanayake, NS | 1 |
Church, NI | 2 |
Chapman, MH | 1 |
Johnson, GJ | 1 |
Dhar, DK | 1 |
Amin, Z | 2 |
Deheragoda, MG | 2 |
Novelli, M | 2 |
Winstanley, A | 1 |
Rodriguez-Justo, M | 2 |
Hatfield, AR | 2 |
Pereira, SP | 2 |
Webster, GJ | 2 |
Tabata, R | 1 |
Tabata, C | 1 |
Okamoto, T | 1 |
Omori, K | 1 |
Terada, M | 1 |
Nagai, T | 1 |
Naitoh, I | 1 |
Nakazawa, T | 1 |
Ohara, H | 1 |
Sano, H | 1 |
Ando, T | 2 |
Hayashi, K | 1 |
Tanaka, H | 1 |
Okumura, F | 1 |
Miyabe, K | 1 |
Yoshida, M | 1 |
Takahashi, S | 1 |
Joh, T | 1 |
Pitchumoni, CS | 1 |
Rubin, A | 1 |
Das, K | 1 |
van Geenen, EJ | 1 |
de Boer, NK | 1 |
Stassen, P | 1 |
Linskens, RK | 1 |
Bruno, MJ | 1 |
Mulder, CJ | 1 |
Stegeman, CA | 1 |
van Bodegraven, AA | 1 |
Vinklerová, I | 1 |
Procházka, M | 1 |
Procházka, V | 1 |
Urbánek, K | 1 |
Lai, SW | 1 |
Wang, YC | 1 |
Wang, CH | 1 |
Huang, TY | 1 |
Venkatesh, PG | 1 |
Navaneethan, U | 1 |
Manfredi, R | 1 |
Frulloni, L | 1 |
Mantovani, W | 1 |
Bonatti, M | 1 |
Graziani, R | 1 |
Pozzi Mucelli, R | 1 |
Bang, S | 1 |
Park, JY | 1 |
Nishikawa, J | 1 |
Kudo, T | 1 |
Miyazaki, T | 1 |
Mihara, H | 1 |
Ueda, A | 1 |
Kajiura, S | 1 |
Fujinami, H | 1 |
Ogawa, K | 1 |
Hosokawa, A | 1 |
Sugiyama, T | 1 |
Wroblova, K | 1 |
Batovsky, M | 1 |
Zboril, V | 1 |
Suchankova, J | 1 |
Bartos, M | 1 |
Ulicny, B | 1 |
Pav, I | 1 |
Minen, F | 1 |
De Cunto, A | 1 |
Gómez, V | 1 |
Michel, JA | 1 |
Floyd, A | 1 |
Pedersen, L | 1 |
Nielsen, GL | 1 |
Thorlacius-Ussing, O | 1 |
Sorensen, HT | 1 |
Toubanakis, C | 1 |
Batziou, E | 1 |
Sipsas, N | 1 |
Galanopoulos, G | 1 |
Tzivras, M | 1 |
Archimandritis, A | 1 |
STARZL, TE | 2 |
MARCHIORO, TL | 1 |
DICKINSON, TC | 1 |
RIFKIND, D | 1 |
STONINGTON, OG | 1 |
WADDELL, WR | 1 |
Johansen, TL | 1 |
Kromann-Andersen, H | 1 |
Perney, P | 1 |
Berthier, E | 1 |
Pageaux, GP | 1 |
Hillaire-Buys, D | 1 |
Roques, V | 1 |
Fabbro-Peray, P | 1 |
Melki, M | 1 |
Hanslik, B | 1 |
Bauret, P | 1 |
Larrey, D | 1 |
Blayac, JP | 1 |
Blanc, F | 1 |
Peters, FT | 2 |
Oostenbrug, LE | 1 |
van den Berg, AP | 1 |
van Haastert, M | 1 |
Ploeg, RJ | 1 |
Posthumus, MD | 1 |
Homan van der Heide, JJ | 1 |
Jansen, PL | 1 |
van Dullemen, HM | 3 |
Mardini, HE | 1 |
Suresh, E | 1 |
Beadles, W | 1 |
Welsby, P | 1 |
Luqmani, R | 1 |
Bajaj, JS | 1 |
Saeian, K | 1 |
Varma, RR | 1 |
Franco, J | 1 |
Knox, JF | 1 |
Podoll, J | 1 |
Emmons, J | 1 |
Levy, M | 1 |
Binion, DG | 1 |
Alexander, S | 1 |
Dowling, D | 1 |
Barabino, A | 1 |
Fontana, M | 1 |
Lionetti, P | 1 |
Malusà, N | 1 |
Bartoli, F | 1 |
Fezzi, M | 1 |
Giraldi, T | 1 |
Van Dieren, JM | 1 |
Van Deventer, HJ | 1 |
Stokkers, PC | 1 |
Van der Woude, JC | 1 |
Van Vuuren, AJ | 1 |
Escher, JC | 1 |
Hommes, DW | 1 |
Soto-Fernández, S | 1 |
González-Carro, P | 1 |
De Pedro-Esteban, A | 1 |
Legaz-Huidobro, ML | 1 |
Pérez-Roldán, F | 1 |
Roncero García-Escribano, O | 1 |
Valbuena-González, M | 1 |
Ruiz-Carrillo, F | 1 |
Bohane, TD | 1 |
Lee, D | 1 |
Naidoo, D | 1 |
Sandanayake, N | 1 |
Lees, WR | 1 |
Gillams, A | 1 |
Seward, EW | 1 |
Kozu, T | 1 |
Sinkovic, A | 1 |
Koren, M | 1 |
Skok, P | 1 |
Potrc, S | 1 |
Batstra, MR | 1 |
Kleibeuker, JH | 1 |
Sleisenger, MH | 1 |
Wuchter, J | 1 |
Reynolds, JC | 1 |
Inman, RD | 1 |
Kimberly, RP | 1 |
Chuong, JH | 1 |
Kovacs, JE | 1 |
Walsh, MB | 1 |
Broe, PJ | 1 |
Cameron, JL | 1 |
Lawson, DH | 1 |
Lovatt, GE | 1 |
Gurton, CS | 1 |
Hennings, RC | 1 |
Guillaume, P | 1 |
Grandjean, E | 1 |
Malè, PJ | 1 |
Pozniak, AL | 2 |
Ahern, M | 1 |
Blake, DR | 1 |
Simons-Ling, N | 1 |
Schachner, L | 1 |
Penneys, N | 1 |
Gorman, H | 1 |
Zillereulo, G | 1 |
Strauss, J | 1 |
Mallory, A | 1 |
Kern, F | 1 |
Whisnant, JK | 1 |
Pelkey, J | 1 |
Lankisch, PG | 1 |
Dröge, M | 1 |
Gottesleben, F | 1 |
Yagisawa, T | 1 |
Toma, H | 1 |
Takahashi, K | 1 |
Tanabe, K | 1 |
Tokumoto, N | 1 |
Iguchi, Y | 1 |
Teraoka, S | 1 |
Ota, K | 2 |
Echarri, A | 1 |
Borda, F | 1 |
Jiménez, FJ | 1 |
Arín, A | 1 |
Martín-Granizo, I | 1 |
Aznarez, R | 1 |
Aissaoui, M | 1 |
Mounedji, N | 1 |
Mathelier-Fusade, P | 1 |
Leynadier, F | 1 |
Keljo, DJ | 1 |
Sugerman, KS | 1 |
Frick, T | 1 |
Foitzik, T | 1 |
Forgacs, B | 1 |
Ryschich, E | 1 |
Hotz, H | 1 |
Gebhardt, MM | 1 |
Buhr, HJ | 1 |
Klar, E | 1 |
Markowitz, JF | 1 |
Marion, JF | 1 |
Tanis, AA | 1 |
Velicia, MR | 1 |
González, JM | 1 |
Fernández, P | 1 |
Remacha, B | 1 |
Martín, MA | 1 |
Sánchez, G | 1 |
Goyeneche, ML | 1 |
Caro-Paton, A | 1 |
Siwach, V | 1 |
Bansal, V | 1 |
Kumar, A | 1 |
Rao Ch, U | 1 |
Minz, M | 1 |
Sakaguchi, T | 1 |
Nakamura, S | 1 |
Suzuki, S | 1 |
Konno, H | 1 |
Fujita, K | 1 |
Suzuki, K | 1 |
Ushiyama, T | 1 |
Ishikawa, A | 1 |
Harada, M | 1 |
Baba, S | 1 |
Glintborg, B | 1 |
Castiglione, F | 1 |
Del Vecchio Blanco, G | 1 |
Rispo, A | 1 |
Mazzacca, G | 1 |
Asztalos, L | 1 |
Kincses, Z | 1 |
Berczi, C | 1 |
Szabo, L | 1 |
Fedor, R | 1 |
Locsey, L | 1 |
Balzs, G | 1 |
Steiner, M | 1 |
Burmeister, D | 1 |
Bastian, M | 1 |
Seiter, H | 1 |
Schuff-Werner, P | 1 |
Wiberg, ME | 1 |
Westermarck, E | 1 |
Le Large-Guiheneuf, C | 1 |
Hugot, JP | 1 |
Faure, C | 1 |
Munck, A | 1 |
Mougenot, JF | 1 |
Navarro, J | 1 |
Cézard, JP | 1 |
Sturdevant, RA | 1 |
Singleton, JW | 1 |
Deren, JL | 1 |
Law, DH | 1 |
McCleery, JL | 1 |
Nakashima, Y | 2 |
Howard, JM | 1 |
Rambaldi, M | 1 |
Russo, R | 1 |
Iaquinto, G | 1 |
Agozzino, L | 1 |
De Cristofano, R | 1 |
Kerstein, MD | 2 |
Grabman, JP | 1 |
Herskowitz, LJ | 1 |
Olansky, S | 1 |
Lang, PG | 1 |
Grabman, J | 1 |
Isenberg, JN | 1 |
Paloyan, D | 1 |
Levin, B | 1 |
Simonowitz, D | 1 |
Castellanos, J | 2 |
Manifacio, G | 2 |
Toledo-Pereyra, LH | 1 |
Shatney, CH | 2 |
Lillehei, RC | 2 |
Toledo-Pereyra, L | 1 |
Frick, TW | 2 |
Fryd, DS | 2 |
Goodale, RL | 2 |
Simmons, RL | 2 |
Sutherland, DE | 2 |
Najarian, JS | 2 |
Roblin, X | 1 |
Becot, F | 1 |
Jacquot, JM | 1 |
Nairi, A | 1 |
Abinader, J | 1 |
Monnet, D | 1 |
Yoshimura, N | 1 |
Nakai, I | 1 |
Ohmori, Y | 1 |
Aikawa, I | 1 |
Fukuda, M | 1 |
Yasumura, T | 1 |
Matsui, S | 1 |
Hamashima, T | 1 |
Oka, T | 1 |
Dobrilla, G | 2 |
Felder, M | 2 |
Chilovi, F | 2 |
Moriello, KA | 1 |
Bowen, D | 1 |
Meyer, DJ | 1 |
Greif, J | 1 |
Erdmann, E | 1 |
Major, GA | 1 |
Moore, PG | 1 |
Khedroo, LG | 1 |
Renning, JA | 1 |
Warden, GD | 1 |
Stevens, LE | 1 |
Reemtsma, K | 1 |
Penn, I | 1 |
Durst, AL | 1 |
Machado, M | 1 |
Halgrimson, CG | 1 |
Booth, AS | 1 |
Putman, CW | 1 |
Groth, CG | 1 |
Thomson, TJ | 1 |
Thiele, KG | 1 |
Kawanishi, H | 1 |
Rudolph, E | 1 |
Bull, FE | 1 |
Van Geertruyden, J | 1 |
Toussaint, C | 1 |
Ginn, HE | 1 |
Mori, S | 1 |
Inou, T | 1 |
Kanazawa, Y | 1 |
Kuzuya, T | 1 |
Nogueira, JR | 1 |
Freedman, MA | 1 |
Leong, RW | 1 |
Mazor, Y | 1 |
Koifman, E | 1 |
Elkin, H | 1 |
Chowers, Y | 1 |
Krivoy, N | 1 |
Efrati, E | 1 |
18 reviews available for azathioprine and Pancreatitis
Article | Year |
---|---|
Immune Checkpoint Inhibitor-related Pancreatitis: A Case Series, Review of the Literature and an Expert Opinion.
Topics: Autoimmune Pancreatitis; Azathioprine; Exocrine Pancreatic Insufficiency; Expert Testimony; Humans; | 2023 |
Pancreatic Disorders in Patients with Inflammatory Bowel Disease.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Pancreatitis; Azathioprin | 2022 |
Immune thrombocytopenic purpura associated with Crohn's disease with complete response to infliximab.
Topics: Adrenal Cortex Hormones; Antirheumatic Agents; Azathioprine; Benzoates; Crohn Disease; Humans; Hydra | 2019 |
Corticosteroid-associated lupus pancreatitis: a case series and systematic review of the literature.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Azathioprine; Cyclophosphamide; Dose-Response Re | 2019 |
Thiopurine-induced pancreatitis in inflammatory bowel diseases.
Topics: Animals; Anti-Inflammatory Agents; Azathioprine; Colitis, Ulcerative; Crohn Disease; Gastrointestina | 2015 |
Toxicity and response to thiopurines in patients with inflammatory bowel disease.
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Colitis, Ulcerative; Crohn Disease; Humans; Im | 2015 |
Patients' Induced Pluripotent Stem Cells to Model Drug Induced Adverse Events: A Role in Predicting Thiopurine Induced Pancreatitis?
Topics: Adaptive Immunity; Animals; Azathioprine; Humans; Immunosuppressive Agents; Induced Pluripotent Stem | 2015 |
Autoimmune Pancreatitis: An Update on Diagnosis and Management.
Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Azathioprine; Biopsy; Cholangiopancreatography, Endosc | 2016 |
Pancreatitis in inflammatory bowel diseases.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Dis | 2010 |
[Drug-induced pancreatitis].
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Azathioprine; | 2007 |
Adverse effects of azathioprine.
Topics: Alopecia; Azathioprine; Bone Marrow Diseases; Carcinogens; Drug Hypersensitivity; Drug Interactions; | 1984 |
Drug-induced pancreatitis: a critical review.
Topics: Acetaminophen; Adrenal Cortex Hormones; Amphetamines; Asparaginase; Azathioprine; Chlorthalidone; Ch | 1980 |
Azathioprine in inflammatory bowel disease, a safe alternative?
Topics: Azathioprine; Bone Marrow; Drug Hypersensitivity; Female; Fertility; Humans; Immunosuppressive Agent | 1998 |
[Acute azathioprine-induced pancreatitis in a female patient with Crohn's disease].
Topics: Acute Disease; Adult; Azathioprine; Crohn Disease; Female; Humans; Immunosuppressive Agents; Pancrea | 1999 |
Drug-induced acute pancreatitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Age Factors; Azathioprin | 1977 |
[Pancreatitis caused by drugs].
Topics: Adult; Azathioprine; Chlorothiazide; Contraceptives, Oral; Drug-Related Side Effects and Adverse Rea | 1977 |
Advances in gastroenterology.
Topics: Adrenal Cortex Hormones; Azathioprine; Chronic Disease; Colitis, Ulcerative; Diet; Disaccharides; Du | 1972 |
Late medical complications of renal transplantation.
Topics: Adrenal Cortex Hormones; Adult; Allopurinol; Autoimmune Diseases; Azathioprine; Bone Diseases; Diabe | 1969 |
5 trials available for azathioprine and Pancreatitis
Article | Year |
---|---|
How should we treat Crohn's disease?
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Clinical Trials as Topic; Crohn Disease; Double-Blind | 1980 |
Subclinical exocrine pancreatic insufficiency in dogs.
Topics: Animals; Azathioprine; Dietary Supplements; Disease Progression; Dog Diseases; Dogs; Enzyme Therapy; | 2002 |
Azathioprine-related pancreatitis in patients with Crohn's disease.
Topics: Adult; Amylases; Azathioprine; Clinical Trials as Topic; Crohn Disease; Double-Blind Method; Female; | 1979 |
Lack of association between azathioprine and acute pancreatitis in renal transplantation patients.
Topics: Acute Disease; Azathioprine; Cyclosporins; Drug Evaluation; Humans; Kidney Transplantation; Pancreat | 1991 |
Hypercalcemia associated with pancreatitis and hyperamylasemia in renal transplant recipients. Data from the Minnesota randomized trial of cyclosporine versus antilymphoblast azathioprine.
Topics: Acute Disease; Amylases; Azathioprine; Clinical Trials as Topic; Cyclosporins; Humans; Hypercalcemia | 1987 |
113 other studies available for azathioprine and Pancreatitis
Article | Year |
---|---|
Frequency, Predisposing Factors, and Clinical Outcome of Azathioprine-Induced Pancreatitis Among Patients With Inflammatory Bowel Disease: Results From a Tertiary Referral Center.
Topics: Abdominal Pain; Acute Disease; Adult; Antimetabolites, Antineoplastic; Azathioprine; Female; Hospita | 2021 |
HLA variants associated with azathioprine-induced pancreatitis in patients with Crohn's disease.
Topics: Acute Disease; Azathioprine; Crohn Disease; HLA-DQ alpha-Chains; HLA-DRB1 Chains; Humans; Inflammato | 2022 |
Finding Predictors of Azathioprine-Induced Pancreatitis in Patients With Inflammatory Bowel Disease.
Topics: Azathioprine; Budesonide; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Pancreatiti | 2022 |
Azathioprine hypersensitivity syndrome manifesting as subcutaneous Sweet syndrome and acute pancreatitis.
Topics: Acute Disease; Azathioprine; Drug Hypersensitivity Syndrome; Humans; Immunosuppressive Agents; Pancr | 2023 |
Safety of Thioguanine in Pediatric Inflammatory Bowel Disease: A Multi-Center Case Series.
Topics: Adolescent; Adult; Azathioprine; Child; Chronic Disease; Cohort Studies; Humans; Immunosuppressive A | 2022 |
Drug-induced acute pancreatitis: Prevalence, Causative agents, and Outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Doxycycline; Drug-Related Side Effects and | 2020 |
A Drug-Induced Acute Pancreatitis Retrospective Study.
Topics: Acute Disease; Azathioprine; Female; Humans; Male; Pancreatitis; Pharmaceutical Preparations; Retros | 2020 |
Recurrent acute pancreatitis induced by 5-ASA and azathioprine in ulcerative colitis.
Topics: Acute Disease; Adult; Azathioprine; Colitis, Ulcerative; Humans; Male; Mesalamine; Pancreatitis; Rec | 2020 |
Pretreatment HLADQA1-HLADRB1 Testing for the Prevention of Azathioprine-Induced Pancreatitis in Inflammatory Bowel Disease: A Prospective Cohort Study.
Topics: Azathioprine; Haplotypes; HLA-DQ alpha-Chains; HLA-DRB1 Chains; Humans; Immunosuppressive Agents; In | 2021 |
Successful use of trametinib and dasatinib combined with chemotherapy in the treatment of Ph-positive B-cell acute lymphoblastic leukemia: A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Azathioprine; Child; Consolidation Che | 2021 |
IgG4-related disease: long-term natural history and management of a relapsing multisystem disease entity.
Topics: Autoimmune Diseases; Azathioprine; Diagnosis, Differential; Hepatitis, Autoimmune; Humans; Immunoglo | 2017 |
HLA-DQA1-HLA-DRB1 polymorphism is a major predictor of azathioprine-induced pancreatitis in patients with inflammatory bowel disease.
Topics: Adult; Azathioprine; Canada; Case-Control Studies; Cohort Studies; Female; Genome-Wide Association S | 2018 |
Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment.
Topics: Aged; Anti-Inflammatory Agents; Autoimmune Diseases; Azathioprine; Bile Duct Diseases; Calculi; Exoc | 2018 |
Letter: predicting azathioprine-associated pancreatitis in IBD-phenotype or genotype? Authors' reply.
Topics: Azathioprine; Genotype; Humans; Inflammatory Bowel Diseases; Pancreatitis; Phenotype | 2018 |
Letter: predicting azathioprine-associated pancreatitis in IBD-phenotype or genotype?
Topics: Azathioprine; Genotype; HLA-DQ alpha-Chains; HLA-DRB1 Chains; Humans; Inflammatory Bowel Diseases; P | 2018 |
Autoimmune Pancreatitis and Ulcerative Rectocolitis in an Adolescent.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Autoimmune Diseases; Azathioprine; Biopsy; Chola | 2018 |
Positioning biologics-A case-based discussion: Ustekinumab.
Topics: Adult; Antibodies, Monoclonal; Australia; Azathioprine; Biosimilar Pharmaceuticals; Crohn Disease; D | 2018 |
Positioning biologics-A case-based discussion: Vedolizumab.
Topics: Adult; Antibodies, Monoclonal, Humanized; Azathioprine; Biosimilar Pharmaceuticals; Crohn Disease; F | 2018 |
Acute pancreatitis and azathioprine in paediatric inflammatory bowel disease.
Topics: Acute Disease; Azathioprine; Child; Cohort Studies; Denmark; Humans; Inflammatory Bowel Diseases; Pa | 2019 |
Association between use of azathioprine and risk of acute pancreatitis in children with inflammatory bowel disease: a Swedish-Danish nationwide cohort study.
Topics: Adolescent; Azathioprine; Case-Control Studies; Child; Child, Preschool; Cohort Studies; Denmark; Fe | 2019 |
Are thiopurines always contraindicated after thiopurine-induced pancreatitis in inflammatory bowel disease?
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Contraindications; Crohn Disease; Drug Monitoring | 2013 |
Tacrolimus as a reasonable alternative in a patient with steroid-dependent and thiopurine-refractory autoimmune pancreatitis with IgG4-associated cholangitis.
Topics: Aged; Azathioprine; Cholangitis; Drug Therapy, Combination; Humans; Immunoglobulin G; Immunosuppress | 2014 |
Effect of tumor necrosis factor-α inhibitors on drug-induced pancreatitis in inflammatory bowel disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Case-Control Studies; Drug Therapy, Co | 2014 |
[Autoimmune pancreatitis--treatment and pitfalls in diagnostics].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Autoimmun | 2014 |
HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants.
Topics: Azathioprine; Gene Frequency; Genetic Predisposition to Disease; Genome-Wide Association Study; Geno | 2014 |
Successful Mercaptopurine Usage despite Azathioprine-Induced Pancreatitis in Paediatric Crohn's Disease.
Topics: Adolescent; Azathioprine; Child; Crohn Disease; Humans; Immunosuppressive Agents; Male; Mercaptopuri | 2015 |
Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases--A Prospective Study on Incidence and Severity.
Topics: Acute Disease; Adult; Age Distribution; Aged; Analysis of Variance; Azathioprine; Colitis, Ulcerativ | 2016 |
A Pitfall to Avoid: Hyperlipasemia, Azathioprine, and Autoimmune Pancreatitis.
Topics: Adult; Autoimmune Diseases; Azathioprine; Colitis, Ulcerative; Female; Humans; Immunosuppressive Age | 2017 |
A case of autoimmune pancreatitis effectively treated with an immunosuppressant (azathioprine).
Topics: Adult; Autoimmune Diseases; Azathioprine; Cholangiopancreatography, Endoscopic Retrograde; Humans; I | 2016 |
Blood group B is associated with azathioprine-induced acute pancreatitis in patients with IBD.
Topics: Azathioprine; Blood Group Antigens; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Ag | 2017 |
Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis.
Topics: Acute Disease; Adult; Antimetabolites; Azathioprine; Cohort Studies; Female; Humans; Inflammatory Bo | 2008 |
Refractory autoimmune pancreatitis: azathioprine or steroid pulse therapy?
Topics: Autoimmune Diseases; Azathioprine; Humans; Immunosuppressive Agents; Pancreatitis; Pulse Therapy, Dr | 2008 |
[A case of acute pancreatitis induced by multiple drugs in a patient with ulcerative colitis].
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Colitis, Ulce | 2008 |
Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Autoimmune Diseases; Azathioprine; Cholang | 2009 |
Autoimmune pancreatitis associated with myelodysplastic syndrome.
Topics: Aged; Amylases; Autoantibodies; Autoimmune Diseases; Azathioprine; Bile Ducts; Bilirubin; Blood Cell | 2010 |
Autoimmune pancreatitis associated with various extrapancreatic lesions during a long-term clinical course successfully treated with azathioprine and corticosteroid maintenance therapy.
Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Azathioprine; Drug Therapy, Combination; Female; Heari | 2009 |
Azathioprine or mercaptopurine-induced acute pancreatitis is not a disease-specific phenomenon.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimetabolites; Azathioprine; Crohn Disease; Female; Humans | 2010 |
Incidence, severity, and etiology of drug-induced acute pancreatitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Child; Child, Preschool; Cr | 2010 |
Acute pancreatitis and erythema nodosum associated with azathioprine.
Topics: Acute Disease; Azathioprine; Dermatitis, Atopic; Dermatologic Agents; Erythema Nodosum; Humans; Immu | 2012 |
Azathioprine induced pancreatitis in a patient with co-existing autoimmune pancreatitis and hepatitis.
Topics: Abdominal Pain; Autoimmune Diseases; Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive | 2011 |
Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence.
Topics: Adult; Aged; Autoimmune Diseases; Azathioprine; Cholangiopancreatography, Magnetic Resonance; Contra | 2011 |
[Suspected pulmonary involvement of autoimmune pancreatitis].
Topics: Autoimmune Diseases; Azathioprine; Common Bile Duct; Emphysema; Fibrosis; Humans; Immunoglobulin G; | 2011 |
[Two cases of thiopurine-induced acute pancreatitis in inflammatory bowel disease].
Topics: Acute Disease; Adolescent; Adult; Azathioprine; Humans; Inflammatory Bowel Diseases; Male; Mercaptop | 2012 |
Gene polymorphisms involved in manifestation of leucopenia, digestive intolerance, and pancreatitis in azathioprine-treated patients.
Topics: Azathioprine; Gastrointestinal Diseases; Gene Expression Regulation; Genetic Predisposition to Disea | 2012 |
Acute and recurrent pancreatitis in children: exploring etiological factors.
Topics: Adolescent; Azathioprine; Biliary Tract; Biliary Tract Diseases; Carrier Proteins; Child; Child, Pre | 2012 |
The great mimicker.
Topics: Aged; Autoimmune Diseases; Azathioprine; Biopsy; Cholangiocarcinoma; Diagnosis, Differential; Female | 2012 |
Risk of acute pancreatitis in users of azathioprine: a population-based case-control study.
Topics: Acute Disease; Adult; Azathioprine; Case-Control Studies; Denmark; Female; Humans; Immunosuppressive | 2003 |
Acute pancreatitis after long-term therapy with mesalazine, and hyperamylasaemia associated with azathioprine in a patient with ulcerative colitis.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Hu | 2003 |
TECHNIQUE OF RENAL HOMOTRANSPLANTATION. EXPERIENCE WITH 42 CASES.
Topics: Azathioprine; Dactinomycin; Diabetes Mellitus; Gastrointestinal Hemorrhage; Humans; Intestinal Obstr | 1964 |
[Picture of the month: recurrent pancreatitis].
Topics: Acute Disease; Adult; Azathioprine; Diagnosis, Differential; Humans; Male; Pancreatitis; Radiography | 2003 |
Are drugs a risk factor of post-ERCP pancreatitis?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Cholangiopancreatography, Endoscopic Retro | 2003 |
Increased incidence of azathioprine-induced pancreatitis in Crohn's disease compared with other diseases.
Topics: Acute Disease; Adult; Antimetabolites; Azathioprine; Crohn Disease; Female; Humans; Male; Middle Age | 2004 |
Azathioprine-induced pancreatitis in Crohn's disease: a smoking gun or guilt by association.
Topics: Acute Disease; Aminosalicylic Acids; Antimetabolites; Azathioprine; Crohn Disease; Humans; Pancreati | 2005 |
Acute pancreatitis with pseudocyst formation in a patient with polyarteritis nodosa.
Topics: Acute Disease; Azathioprine; Cyclophosphamide; Cysts; Drug Therapy, Combination; Humans; Immunosuppr | 2005 |
Azathioprine-induced pancreatitis in Crohn's disease: a smoking gun or guilt by association. Author's reply.
Topics: Acute Disease; Antimetabolites; Azathioprine; Crohn Disease; Humans; Pancreatitis | 2005 |
Increased rates of early adverse reaction to azathioprine in patients with Crohn's disease compared to autoimmune hepatitis: a tertiary referral center experience.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Arthralgia; Azathioprine; Crohn Disease; Disease Sus | 2005 |
Azathioprine pancreatitis in inflammatory bowel disease and successful subsequent treatment with mercaptopurine.
Topics: Adult; Azathioprine; Crohn Disease; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Merca | 2005 |
TPMT genotype and the use of thiopurines in paediatric inflammatory bowel disease.
Topics: Adolescent; Adult; Azathioprine; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Child | 2005 |
Pharmacogenetics of thiopurine therapy in paediatric IBD patients.
Topics: Adolescent; Azathioprine; Chi-Square Distribution; Child; Female; Gene Frequency; Genetic Predisposi | 2006 |
[Infliximab-induced hepatitis in a patient with Crohn's disease].
Topics: Acute Disease; Adult; Antibodies, Monoclonal; Azathioprine; Chemical and Drug Induced Liver Injury; | 2006 |
Thiopurine metabolite monitoring in paediatric inflammatory bowel disease.
Topics: Adolescent; Azathioprine; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug Hype | 2007 |
Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series.
Topics: Adult; Aged; Autoimmune Diseases; Azathioprine; Cholangiopancreatography, Endoscopic Retrograde; Com | 2007 |
[Acute pancreatitis following azathioprine therapy of crohn's disease--a case report and the overview of the literature].
Topics: Acute Disease; Adult; Azathioprine; Crohn Disease; Female; Humans; Immunosuppressive Agents; Pancrea | 2008 |
Are pancreatic autoantibodies associated with azathioprine-induced pancreatitis in Crohn's disease?
Topics: Adult; Autoantibodies; Azathioprine; Case-Control Studies; Crohn Disease; Female; Humans; Immunosupp | 2008 |
[Conservative therapy of Crohn disease].
Topics: Adrenal Cortex Hormones; Azathioprine; Crohn Disease; Humans; Pancreatitis; Psychotherapy; Pyridazin | 1982 |
Acute pancreatitis in systemic lupus erythematosus: report of twenty cases and a review of the literature.
Topics: Acute Disease; Adolescent; Adult; Aged; Amylases; Azathioprine; Female; Humans; Lupus Erythematosus, | 1982 |
Azathioprine and acute pancreatitis: studies with an isolated perfused canine pancreas.
Topics: Acute Disease; Amylases; Animals; Azathioprine; Blood Glucose; Disease Models, Animal; Dogs; Pancrea | 1983 |
Azathioprine-associated acute pancreatitis in the course of chronic active hepatitis.
Topics: Acute Disease; Adult; Azathioprine; Hepatitis B Surface Antigens; Hepatitis, Chronic; Humans; Male; | 1984 |
Azathioprine-induced shock.
Topics: Aged; Arthritis, Rheumatoid; Azathioprine; Humans; Male; Pancreatitis | 1981 |
Childhood systemic lupus erythematosus. Association with pancreatitis, subcutaneous fat necrosis, and calcinosis cutis.
Topics: Adipose Tissue; Azathioprine; Calcinosis; Child; Female; Humans; Hydrochlorothiazide; Lupus Erythema | 1983 |
Rheumatoid arthritis: treatment with azathioprine (IMURAN (R)). Clinical side-effects and laboratory abnormalities.
Topics: Adult; Aged; Anorexia; Arthritis, Rheumatoid; Azathioprine; Bacterial Infections; Chemical and Drug | 1982 |
Azathioprine-induced pancreatitis.
Topics: Azathioprine; Humans; Pancreatitis | 1982 |
Drug induced acute pancreatitis: incidence and severity.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Azathioprine; Didanosine; Estrogens; Female; Furosemi | 1995 |
Peritoneal lavage therapy for severe acute pancreatitis after renal transplantation.
Topics: Acute Disease; Adult; Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplan | 1996 |
[Acute pancreatitis caused by azathioprine in patient with Crohn disease].
Topics: Acute Disease; Adult; Azathioprine; Crohn Disease; Female; Humans; Immunosuppressive Agents; Pancrea | 1996 |
[Pancreatitis caused by azathioprine: immuno-allergy?].
Topics: Acute Disease; Adult; Azathioprine; Crohn Disease; Drug Hypersensitivity; Humans; Male; Pancreatitis | 1996 |
Pancreatitis in patients with inflammatory bowel disease.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Azathioprine; | 1997 |
Drug-associated pancreatitis: facts and fiction.
Topics: Acute Disease; Azathioprine; Furosemide; Humans; Pancreatitis; Sulfonamides; Tetracycline | 1997 |
Effect of different immunosuppressive agents on acute pancreatitis: a comparative study in an improved animal model.
Topics: Acute Disease; Animals; Azathioprine; Cyclosporine; Immunosuppressive Agents; Male; Muromonab-CD3; N | 1998 |
Summary of the workshop on 6-mercaptopurine/azathioprine pharmacology.
Topics: Adult; Azathioprine; Child; Colitis, Ulcerative; Crohn Disease; Drug Interactions; Drug Therapy, Com | 1998 |
Toxicity of 6-mercaptopurine/azathioprine in patients with inflammatory bowel disease.
Topics: Adolescent; Adult; Azathioprine; Bone Marrow; Child; Colorectal Neoplasms; Drug Hypersensitivity; Fe | 1998 |
Post-renal transplant azathioprine-induced pancreatitis.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Kidney Transplantation; Magnetic Resonance Imaging; | 1999 |
Intracystic hemorrhage of pancreatic serous cystadenoma after renal transplantation: report of a case.
Topics: Adult; Azathioprine; Cystadenoma, Serous; Disease Progression; Hemorrhage; Humans; Immunosuppressive | 2000 |
[Pancreatitis in a patient with Crohn disease treated with mesalazine and azathioprine].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Female; Humans; Mesalam | 2000 |
Prevention of pancreatitis by weekly amylase assay in patients with Crohn's disease treated with azathioprine.
Topics: Amylases; Azathioprine; Biomarkers; Crohn Disease; Humans; Immunoenzyme Techniques; Immunosuppressiv | 2000 |
[Acute pancreatitis after kidney transplantation].
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Azathioprine; Cadaver; Cyclosporine; Female; Humans; | 2001 |
Elevated serum pancreatic enzyme activities in kidney transplant recipients and azathioprine drug therapy: is thiopurine methyltransferase polymorphism one missing link?
Topics: Alleles; Amylases; Azathioprine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; L | 2002 |
[Pancreatic involvement in inflammatory bowel diseases in children].
Topics: Adolescent; Amylases; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; Colitis, Ulcerat | 2002 |
[Drug-induced acute pancreatitis (author's transl)].
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Aged; Azathi | 1979 |
Azathioprine as a treatment modality in acute hemorrhagic pancreatitis.
Topics: Acute Disease; Animals; Azathioprine; Dogs; Hemorrhage; Pancreatic Diseases; Pancreatitis; Survival | 1978 |
Acute pancreatitis associated with long-term azathioprine therapy. Occurrence in a patient with systemic lupus erythematosus.
Topics: Acute Disease; Adult; Azathioprine; Female; Humans; Lupus Erythematosus, Systemic; Pancreatitis; Pre | 1979 |
Amelioration of pancreatitis with azathioprine.
Topics: Acute Disease; Animals; Azathioprine; Bile; Dogs; Female; Male; Pancreatitis; Trypsin | 1979 |
Pancreatitis, amylase clearance, and azathioprine.
Topics: Adolescent; Amylases; Azathioprine; Creatinine; Humans; Male; Pancreatitis | 1978 |
Azathioprine-associated acute pancreatitis.
Topics: Acute Disease; Adult; Azathioprine; Crohn Disease; Granuloma; Humans; Male; Pancreatitis | 1977 |
Consistent protection from pancreatitis in canine pancreas allografts treated with 5-fluorouracil.
Topics: Administration, Oral; Animals; Autopsy; Azathioprine; Dogs; Drug Synergism; Female; Fluorouracil; In | 1975 |
Prolongation of pancreatic allograft survival by 5-fluorouracil.
Topics: Animals; Azathioprine; Dogs; Fluorouracil; Graft Rejection; Humans; Immunosuppression Therapy; Pancr | 1975 |
[Azathioprine-induced acute pancreatitis].
Topics: Acute Disease; Adult; Azathioprine; Female; Humans; Pancreatitis | 1990 |
Effect of cyclosporine on the endocrine and exocrine pancreas in kidney transplant recipients.
Topics: Acute Disease; Adult; Amylases; Azathioprine; Blood Glucose; Cyclosporins; Diabetes Mellitus; Drug T | 1988 |
[Proven relationship between drugs and pancreatitis].
Topics: Asparaginase; Azathioprine; Diuretics; Drug-Related Side Effects and Adverse Reactions; Estrogens; H | 1986 |
Acute pancreatitis in two dogs given azathioprine and prednisone.
Topics: Acute Disease; Animals; Azathioprine; Dog Diseases; Dogs; Drug Synergism; Male; Pancreatitis; Predni | 1987 |
[Life-threatening interaction between azathioprine and allopurinol].
Topics: Allopurinol; Azathioprine; Chemical and Drug Induced Liver Injury; Drug Synergism; Drug Therapy, Com | 1985 |
[Acute drug-induced pancreatitis].
Topics: Acute Disease; Asparaginase; Azathioprine; Chlorothiazide; Drug-Related Side Effects and Adverse Rea | 1985 |
Profound circulatory collapse due to azathioprine.
Topics: Acute Kidney Injury; Arthritis, Rheumatoid; Azathioprine; Female; Humans; Jaundice; Middle Aged; Pan | 1985 |
Application of therapeutic agents to alter the course of acute hemorrhagic pancreatitis in dogs.
Topics: Acute Disease; Aminocaproates; Animals; Aprotinin; Azathioprine; Bile; Bile Ducts; Convalescence; Do | 1974 |
Pancreatitis after renal transplantation.
Topics: Adult; Azathioprine; Female; Glomerulonephritis; Graft Rejection; Humans; Kidney Failure, Chronic; K | 1972 |
Acute pancreatitis and hyperamylasemia in renal homograft recipients.
Topics: Adolescent; Adult; Amylases; Azathioprine; Calcium; Cholelithiasis; Creatinine; Female; Humans; Hype | 1972 |
[Therapy of enteritis regional Crohn using azathioprine].
Topics: Abscess; Azathioprine; Crohn Disease; Humans; Pancreatitis; Prospective Studies; Sepsis | 1973 |
Azathioprine-induced acute pancreatitis.
Topics: Acute Disease; Adolescent; Azathioprine; Crohn Disease; Female; Humans; Pancreatitis | 1973 |
[Acute pancreatitis after renal transplantation].
Topics: Acute Disease; Adult; Azathioprine; Cadaver; Female; Glomerulonephritis; Humans; Kidney Transplantat | 1967 |
Endocrine function of the pancreatic allograft.
Topics: Animals; Azathioprine; Blood Glucose; Dogs; Glucose Tolerance Test; Graft vs Host Disease; Hyperglyc | 1968 |
Acute pancreatitis as a complication of Imuran therapy in regional enteritis.
Topics: Acute Disease; Amylases; Azathioprine; Crohn Disease; Female; Humans; Middle Aged; Pancreatitis; Tim | 1972 |
Positioning biological agents: Session two summary.
Topics: Adult; Antibodies, Monoclonal, Humanized; Crohn Disease; Digestive System Surgical Procedures; Femal | 2018 |
Risk factors for serious adverse effects of thiopurines in patients with Crohn's disease.
Topics: Adolescent; Adult; Age Factors; Chemical and Drug Induced Liver Injury; Cohort Studies; Crohn Diseas | 2013 |